Bisdiazabicyclo compound for treatment and/or prevention of hepatitis virus-related diseases or disorders
AssigneesJiangsu Ascentage Biomed Development Inc., Healthquest Pharma Inc.
InventorsYifan Zhai, Xiaoyong Zhang, Jinlin Hou, Dajun Yang
Life of this patent
Estimating the term…
Abstract
Disclosed are a bisdiazabicyclo compound for treating and/or preventing hepatitis virus-related diseases or disorders, a method for treating and/or preventing hepatitis virus-related diseases or disorders by using the bisdiazabicyclo compound, and a use of the bisdiazabicyclo compound in the preparation of a drug for treating and/or preventing hepatitis virus-related diseases or disorders, and/or eliminating or mitigating hepatitis virus-related diseases or disorders.
Claims5
A method of using a compound for treatment of a disease or disorder associated with a hepatitis virus, wherein the method comprises administering a therapeutically effective amount of the compound to a patient having the disease or disorder associated with a hepatitis virus, and the compound is a bisdiazabicyclo compound or a pharmaceutically acceptable salt thereof,
- wherein the disease or disorder associated with hepatitis virus is hepatitis A, hepatitis B, hepatitis C, or liver cirrhosis, and
- the compound is
A method of treating a patient having hepatitis B, comprising administering to the patient a therapeutically effective amount of a compound, wherein the compound is
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.